Literature DB >> 23582264

[Lung adenocarcinoma with intramedullary spinal cord metastasis: a case report and review of the literature].

I Belaid1, H Jlassi, G Debbiche, H Rais, F Ben Ayed.   

Abstract

Intramedullary spinal cord metastases are extremely rare and affect 0.1 to 0.4% of all cancer patients. We report the case of intramedullary metastases in a 42-year-old patient, 12 months after the initial diagnosis of a lung adenocarcinoma. The patient was on third-line chemotherapy for a progressive disease with node and bone metastases. He complained of weakness and difficulty walking. The MRI permitted confirmation of the diagnosis. Corticotherapy was started and the patient underwent radiotherapy. A targeted therapy was indicated. The patient died three months after the initiation of this treatment. The aim of this paper is to report a new case of intramedullary spinal cord metastases from a pulmonary adenocarcinoma, focus on its rarity and diagnostic and therapeutic difficulties through a review of the literature.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23582264     DOI: 10.1016/j.pneumo.2013.02.007

Source DB:  PubMed          Journal:  Rev Pneumol Clin        ISSN: 0761-8417


  3 in total

1.  Clinical Reasoning: an unusual cause of transverse myelitis?

Authors:  Pavan Bhargava; Rodger J Elble
Journal:  Neurology       Date:  2014-02-11       Impact factor: 9.910

2.  Successful osimertinib treatment in a patient who exhibited intramedullary spinal cord metastases of lung adenocarcinoma with an acquired EGFR T790M mutation.

Authors:  Kohei Horiuchi; Takanori Asakura; Shinji Sakaguchi; Fumitake Saito
Journal:  BMJ Case Rep       Date:  2019-06-21

3.  [Intramedullary metastasis of lung adenocarcinoma: about a case].

Authors:  Hicham Naji-Amrani; Hicham Janah; Fatimazahra Sqalli; Hicham Souhi; Adil Zegmout; Hanane Elouazzani; Ismail Abderrahmani Rhorfi; Ahmed Abid
Journal:  Pan Afr Med J       Date:  2015-01-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.